RAD51 Expression as a Biomarker to Predict Efficacy of Preoperative Therapy and Survival for Esophageal Squamous Cell Carcinoma-Reference-Cited by-同舟云学术

RAD51 Expression as a Biomarker to Predict Efficacy of Preoperative Therapy and Survival for Esophageal Squamous Cell Carcinoma

Published:2020-05-29 Issue: Volume:Publish Ahead of Print Page:
ISSN:0003-4932
Container-title:Annals of Surgery
language:en
Short-container-title:

Author:

Saeki Hiroshi,Jogo Tomoko,Kawazoe Tetsuro,Kamori Tomohiro,Nakaji Yu,Zaitsu Yoko,Fujiwara Minako,Baba Yoshifumi,Nakamura Tetsu,Iwata Naoki,Egashira Akinori,Nakanoko Tomonori,Morita Masaru,Tanaka Yoshihiro,Kimura Yasue,Shibata Tomotaka,Nakashima Yuichiro,Emi Yasunori,Makiyama Akitaka,Oki Eiji,Tokunaga Shoji,Shimokawa Mototsugu,Mori Masaki

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Surgery

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Dual-loss of PBRM1 and RAD51 identifies hyper-sensitive subset patients to immunotherapy in clear cell renal cell carcinoma;Cancer Immunology, Immunotherapy;2024-04-12

2. Antitumor Activity of the Xanthonoside XGAc in Triple-Negative Breast, Ovarian and Pancreatic Cancer by Inhibiting DNA Repair;Cancers;2023-12-06

3. Expression of Polyadenylate-binding Protein Cytoplasmic 1 (PABPC1) in Combination With RAD51 as Prognostic Biomarker in Patients Who Underwent Postoperative Chemotherapy for Esophageal Squamous Cell Carcinoma;Applied Immunohistochemistry & Molecular Morphology;2023-02-06

4. Simple Cancer Stem Cell Markers Predict Neoadjuvant Chemotherapy Resistance of Esophageal Squamous Cell Carcinoma;Anticancer Research;2021-07-19

5. New RAD51 Inhibitors to Target Homologous Recombination in Human Cells;Genes;2021-06-16